Literature DB >> 31573162

Hand-Foot-and-Mouth Disease: Rapid Evidence Review.

Aaron Saguil1, Shawn F Kane2, Rebecca Lauters3, Michael G Mercado4.   

Abstract

Hand-foot-and-mouth disease is caused by human enteroviruses and coxsackieviruses. Outbreaks can occur in the spring to fall and are common in North America, and most cases occur in patients younger than 10 years. Hand-foot-and-mouth disease is transmitted by fecal-oral, oral-oral, and respiratory droplet contact. Patients present with a low-grade fever, a maculopapular or papulovesicular rash on the hands and soles of the feet, and painful oral ulcerations. Lesions usually resolve in seven to 10 days; however, in rare cases, patients may have neurologic or cardiopulmonary complications. The differential diagnosis for childhood rashes and oral enanthems is broad and includes erythema multiforme, herpes, measles, and varicella. Treatment is supportive and directed toward hydration and pain relief as needed with acetaminophen or ibuprofen. Oral lidocaine is not recommended, and antiviral treatment is not available. The best methods to prevent the spread of hand-foot-and-mouth disease are handwashing and disinfecting potentially contaminated surfaces and fomites.

Entities:  

Mesh:

Year:  2019        PMID: 31573162

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  9 in total

Review 1.  [Palmoplantar dermatoses in children].

Authors:  M Knop; N Alelq; M E Kubieniec; K Giehl
Journal:  Hautarzt       Date:  2021-02-12       Impact factor: 0.751

2.  circRNA expression patterns and circRNA-miRNA-mRNA networks during CV-A16 infection of SH-SY5Y cells.

Authors:  Yajie Hu; Ruian Yang; Wei Zhao; Chen Liu; Yan Tan; Dandan Pu; Jie Song; Yunhui Zhang
Journal:  Arch Virol       Date:  2021-08-19       Impact factor: 2.574

3.  A 10-Day-Old Murine Model of Coxsackievirus A6 Infection for the Evaluation of Vaccines and Antiviral Drugs.

Authors:  Zaixue Jiang; Yaozhong Zhang; Huayuan Lin; Qingqiu Cheng; Xiaomei Lu; Wenkuan Liu; Rong Zhou; Baimao Zhong; Xingui Tian
Journal:  Front Immunol       Date:  2021-05-13       Impact factor: 7.561

4.  Associations between ambient air pollution and daily incidence of pediatric hand, foot and mouth disease in Ningbo, 2014-2016: a distributed lag nonlinear model.

Authors:  Shaohua Gu; Decheng Li; Beibei Lu; Ruixue Huang; Guozhang Xu
Journal:  Epidemiol Infect       Date:  2020-03-04       Impact factor: 2.451

5.  Application Effect of Medical Care Integration Combined with Family Intervention under the Evidence-Based Nursing Mode on Child Patients with Severe Hand-Foot-Mouth Disease and Its Influence on Intestinal Function.

Authors:  Zhaofang Zhang; Mei Dong; Yuejiao Han; Hui Lin; Anying Li; Na Wang; Xia Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2021-10-11       Impact factor: 2.629

6.  Hand, Foot, and Mouth Disease Associated With Transient Hyperphosphatasemia.

Authors:  Anisha Verma; Benjamin Keaton; Aaron McGuffin
Journal:  Cureus       Date:  2022-02-09

7.  Spatial-temporal-demographic and virological changes of hand, foot and mouth disease incidence after vaccination in a vulnerable region of China.

Authors:  Li Huang; Ting Wang; Jian Cheng; Yinguang Fan; Xuxiang Liu; Yuansheng Fu; Sichen Zhang; Qinshu Chu; Tingyue Nie; Houmian Tu
Journal:  BMC Public Health       Date:  2022-08-01       Impact factor: 4.135

8.  Comprehensive profiling and characterization of cellular microRNAs in response to coxsackievirus A10 infection in bronchial epithelial cells.

Authors:  Yajie Hu; Lan Wang; Mingmei Zhong; Wei Zhao; Yujue Wang; Jie Song; Yunhui Zhang
Journal:  Virol J       Date:  2022-07-21       Impact factor: 5.913

9.  Time Series Analysis and Forecasting of the Hand-Foot-Mouth Disease Morbidity in China Using An Advanced Exponential Smoothing State Space TBATS Model.

Authors:  Chongchong Yu; Chunjie Xu; Yuhong Li; Sanqiao Yao; Yichun Bai; Jizhen Li; Lei Wang; Weidong Wu; Yongbin Wang
Journal:  Infect Drug Resist       Date:  2021-07-21       Impact factor: 4.003

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.